Journal article
The Role of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi: A Meta-Analysis and Systematic Review
American journal of cardiovascular drugs : drugs, devices, and other interventions, Vol.21(4), pp.435-441
07/01/2021
DOI: 10.1007/s40256-020-00458-2
PMID: 33354748
Abstract
Background
Direct oral anticoagulants (DOACs) have a well-established role in the treatment of deep vein thrombosis and pulmonary embolism and in the reduction of thromboembolism in nonvalvular atrial fibrillation. However, limited evidence supports their role in patients with left ventricular thrombi.
Methods
The PubMed, EMBASE, and Cochrane databases were searched for relevant articles published from inception to 1 August 2020. We included studies evaluating the effect of DOACs versus vitamin K antagonists (VKAs) in patients with left ventricular thrombi. The primary outcome was thrombus resolution, and the secondary outcomes were major bleeding and stroke or systemic embolization (SSE).
Results
Five retrospective observational studies were included, with a total of 857 patients. VKAs and DOACs had a similar rate of thrombus resolution (odds ratio [OR] 0.97; 95% confidence interval [CI] 0.57–1.65;
p
= 0.90). Our analysis also demonstrated a similar rate of major bleeding (OR 0.62; 95% CI 0.27–1.44;
p
= 0.27) and SSE (OR 1.86; 95% CI 0.99–3.50;
p
= 0.05) between the two treatment groups.
Conclusion
In patients with left ventricular thrombi, DOACs and VKAs are associated with similar rates of thrombus resolution, major bleeding, and SSE.
Details
- Title: Subtitle
- The Role of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi: A Meta-Analysis and Systematic Review
- Creators
- Abdullah Al-abcha - Michigan State UniversityKhader Herzallah - Tufts UniversityYehia Saleh - Houston MethodistMark Mujer - Michigan State UniversityOla Abdelkarim - Alexandria UniversityMahmoud Abdelnabi - Alexandria UniversityAbdallah Almaghraby - Alexandria UniversityGeorge S. Abela - Michigan State University
- Resource Type
- Journal article
- Publication Details
- American journal of cardiovascular drugs : drugs, devices, and other interventions, Vol.21(4), pp.435-441
- Publisher
- Springer International Publishing
- DOI
- 10.1007/s40256-020-00458-2
- PMID
- 33354748
- ISSN
- 1175-3277
- eISSN
- 1179-187X
- Number of pages
- 7
- Language
- English
- Date published
- 07/01/2021
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984755393202771
Metrics
3 Record Views